Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119398) titled 'Artificial intelligence-driven hypertension risk prediction and clinical validation study' on Feb. 26.

Study Type: Diagnostic test

Study Design: Diagnostic test: case-control

Primary Sponsor: Handan First Hospital

Condition: Hypertension

Intervention: Gold Standard:Cardiology experts make judgments based on complete medical records

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-02-01

Target Sample Size: Target condition:700;Difficult condition:0

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=304899

Published by HT Digit...